Latest News

Date Title Topic
17 Apr 2015 ELCC 2015 Press Release: Smokers Underestimate Risks of a Few Cigarettes Epidemiology/Etiology/Cancer Prevention - Lung and other thoracic tumours
17 Apr 2015 ELCC 2015 Press Release: Evidence Grows that Melanoma Drugs Benefit some Lung Cancer Patients Lung and other thoracic tumours - Anticancer agents & Biologic therapy
16 Apr 2015 ELCC 2015 News: ‘Real-World’ EGFR Mutation Frequency Results From a Large Population of Chemotherapy Naive Patients With Advanced NSCLC Personalised medicine - Translational research - Lung and other thoracic tumours
16 Apr 2015 ELCC 2015 News: Neoadjuvant Erlotinib in Endobronchial Ultrasound Confirmed Stage IIIA-N2 NSCLC Lung and other thoracic tumours - Anticancer agents & Biologic therapy
16 Apr 2015 ELCC 2015 News: Promising Results for Surgical Salvage of Local Recurrences after Stereotactic Ablative Radiotherapy in Patients With Early-Stage NSCLC Personalised medicine - Translational research - Lung and other thoracic tumours
16 Apr 2015 ELCC 2015 News: VEGF SNPs Identified as Prognostic Markers for Bevacizumab Response in Patients with Advanced Non-Squamous NSCLC Translational research - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
13 Apr 2015 ELCC 2015 Press Release: First Heine H. Hansen Award goes to Pieter E. Postmus
02 Apr 2015 'Big Bang' Model of Cancer Heterogeneity Translational research
01 Apr 2015 European Medicines Agency Recommends Granting a Marketing Authorisation for Gardasil 9 Human Papillomavirus 9-Valent Vaccine (Recombinant, Adsorbed) Epidemiology/Etiology/Cancer Prevention
31 Mar 2015 Clinicians Hail Benefits of ESMO Clinical Practice Guidelines Gastrointestinal cancers
31 Mar 2015 European Medicines Agency Recommends Granting a Marketing Authorisation for a Fixed Dose Combination Netupitant/Palonosetron Palliative and supportive care
30 Mar 2015 European Medicines Agency Recommends Granting a Marketing Authorisation for Lenvatinib Endocrine cancers - Anticancer agents & Biologic therapy
27 Mar 2015 ESMO Press Release: Clinical Trial Design in the Era of Targeted Therapies Translational research